Women Are Dying From Hormone Therapy: Why Is It Still Available & Recommended?

Big Pharma is still pushing its hormone therapy for women, despite the fact that it increaseswomen’s risk of cancer and other health problems.

Pharma’s lucrative estrogen plus progestin combo is already known to increase the chance of getting breast cancer by 26 %. But an article in this week’s Journal of the American Medical Association (JAMA) shows hormone therapy also increases the chance of dying from breast cancer, as follow ups are conducted on women who took it.

In fact hormone therapy, already indicted for causing delays in breast cancer diagnosis by increasing breast density (& increasing lung cancer deaths) is now so dangerous that Peter B. Bach of the Memorial Sloan-Kettering Cancer Center, who wrote an accompanying JAMA editorial, told the New York Times that even the recommendation to take “the lowest possible doses for the shortest possible time” is now questionable. Perhaps like prescribing the fewest and lowest tar cigarettes as possible.

Given over 5,000 lawsuits in USA brought by women with hormone therapy-caused breast cancer, why is it still on the market? Why is it being tested (with tax dollars) to extend the franchise into a new generation of women? And why is it still presented to women as a “choice”? As in We Warned You.